You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Bamlanivimab

Showing 1 - 17 of 17
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial (Bamlanivimab)

No longer available
  • COVID-19
  • Bamlanivimab
  • (no location specified)
Jan 16, 2023

Covid19 Trial in Minnetonka (bamlanivimab)

Terminated
Has Results
  • Covid19
  • bamlanivimab
  • Minnetonka, Minnesota
    QueryLab
Mar 16, 2022

Covid19 Trial in Pittsburgh (Lilly Bamlanivimab, Regeneron Casirivimab + Imdevimab, Lilly Bamlanivimab + Etesevimab)

Completed
  • Covid19
  • Lilly Bamlanivimab
  • +4 more
  • Pittsburgh, Pennsylvania
    UPMC
Jun 16, 2022

COVID-19 Trial in Albuquerque (Bamlanivimab)

Completed
Has Results
  • COVID-19
  • Bamlanivimab
  • Albuquerque, New Mexico
    Presbyterian Medical Center
Nov 11, 2021

Covid19 Trial in Edinburg, Rio Grande City (BAMLANIVIMAB, CASIRIVIMAB, IMDEVIMAB)

Recruiting
  • Covid19
  • BAMLANIVIMAB
  • +2 more
  • Edinburg, Texas
  • +2 more
Mar 14, 2022

Covid19 Trial in Fraser Health Region (Bamlanivimab, Standard of Care)

Active, not recruiting
  • Covid19
  • Bamlanivimab
  • Standard of Care
  • Fraser Health Region, British Columbia, Canada
    Fraser Health Authority
Aug 24, 2021

Healthy Trial in Daytona Beach (LY3819253, Placebo)

Completed
Has Results
  • Healthy
  • Daytona Beach, Florida
    Covance Clinical Research Inc
Nov 1, 2021

Covid19, Nosocomial Infection, SARS-CoV2 Infection Trial in Canada (Anti-SARS-CoV-2 mAb)

Suspended
  • Covid19
  • +2 more
  • Anti-SARS-CoV-2 mAb
  • Calgary, Alberta, Canada
  • +3 more
Nov 30, 2021

A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies

Recruiting
  • Immunocompromised Patients
  • Data collection
  • Paris, Ile De France, France
    Assistance Publique - Hôpitaux de Paris (AP-HP) - Cochin Hospita
Jul 5, 2022

COVID-19 Complications in High-risk Subjects Infected by

Recruiting
  • SARS-CoV Infection
  • Covid19
  • biobank
  • Agen, France
  • +36 more
Apr 6, 2022

TURN-COVID Biobank: The Dutch Cohort Study for Evaluation of Use

Recruiting
  • COVID-19
  • casirivimab with imdevimab
  • +2 more
  • Amsterdam, Noord Holland, Netherlands
  • +3 more
Jan 13, 2022

COVID-19 Trial in France, Germany, United Kingdom (COVID-19 convalescent and vaccinated plasma, Current standard of care)

Recruiting
  • COVID-19
  • COVID-19 convalescent and vaccinated plasma
  • Current standard of care
  • Besançon, France
  • +10 more
May 3, 2022

COVID-19 Trial in Argentina, Puerto Rico, United States (Bamlanivimab, Etesevimab, Placebo)

Completed
Has Results
  • COVID-19
  • Bamlanivimab
  • +4 more
  • Birmingham, Alabama
  • +140 more
Jun 7, 2022

COVID-19 Trial in Worldwide (LY3819253, Placebo, Remdesivir)

Completed
  • COVID-19
  • LY3819253
  • +2 more
  • Tucson, Arizona
  • +56 more
Mar 22, 2023

Covid19 Virus Infection Trial in Rockville (Inflammation (I), Inflammation (II), Inflammation (III))

Recruiting
  • Covid19 Virus Infection
  • Inflammation (I)
  • +3 more
  • Rockville, Maryland
    All Natural Medicine Clinic, LLC
Oct 31, 2021

COVID-19 Trial in Worldwide (AZD7442, Placebo)

Completed
Has Results
  • COVID-19
  • Jasper, Alabama
  • +102 more
Jan 14, 2023

COVID-19 Trial in Worldwide (VIR-7831, Placebo, Remdesivir)

Completed
  • COVID-19
  • VIR-7831
  • +2 more
  • Tucson, Arizona
  • +104 more
Mar 22, 2023